State and federal legislative interests
Purpose - This paper aims to briefly describe the increasingly complex array of organizations influencing American healthcare-associated infection (HAI) prevention efforts during the modern era of infection control.Design methodology approach - This paper is a narrative review.Findings - The modern...
Gespeichert in:
| Veröffentlicht in: | Clinical governance 2012, Vol.17 (2), p.141-148 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 148 |
|---|---|
| container_issue | 2 |
| container_start_page | 141 |
| container_title | Clinical governance |
| container_volume | 17 |
| creator | Birnbaum, David Stricof, Rachel |
| description | Purpose - This paper aims to briefly describe the increasingly complex array of organizations influencing American healthcare-associated infection (HAI) prevention efforts during the modern era of infection control.Design methodology approach - This paper is a narrative review.Findings - The modern era of hospital infection control began in the 1950s, but received relatively little publicity until the dawn of the twenty-first century. Since then, there has been a wave of unprecedented magnitude in individual state legislation mandates followed by a shift from state to federal agency activity. The resulting programs are in varying stages of development, ability, sustainability, and coordination.Practical implications - Many government and healthcare entities are in uncharted territory with this new area of activity, facing challenges in having to coordinate work with many new and unfamiliar partners. Perspectives explored in this part of the Universities Council Symposium help by mapping out the various stakeholders in order to foster a research agenda through better understanding of powerful political players and their influence.Originality value - This is one of the first efforts to describe and map the evolving range of state and federal forces influencing hospitals' efforts to prevent healthcare-associated infections. |
| doi_str_mv | 10.1108/14777271211220853 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1023091751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1022889616</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-f000650b44902b9c0dabf26a414931b9593e8e8e9fa425ad347f63bc1f5424813</originalsourceid><addsrcrecordid>eNqN0E1LxDAQBuAgCq6rP8BbwYMerM4kkzQ5yuIXLHhQzyVtE-nSbdekK_jvzbKCoCxIDgnMMxnmZewU4QoR9DVSURS8QI7IOWgp9tgEC6lzBULvp3eq5wnQITuKcQHAgQAm7Px5tKPLbN9k3jUu2C7r3FsbOzu2Hy5r-9EFF8d4zA687aI7-b6n7PXu9mX2kM-f7h9nN_O85prG3AOAklARGeCVqaGxlefKEpIRWBlphNPpGG-JS9sIKrwSVY1eEieNYsoutv-uwvC-TpPLZRtr13W2d8M6lghcgEmb_YtyrY1ClejZL7oY1qFPiyQFWhFIs1G4VXUYYgzOl6vQLm34TKjcpFz-STn1XG573HITXvPT8puWq8YnDjv4zglfscKHBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1008640596</pqid></control><display><type>article</type><title>State and federal legislative interests</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Emerald Complete Journals</source><creator>Birnbaum, David ; Stricof, Rachel</creator><creatorcontrib>Birnbaum, David ; Stricof, Rachel</creatorcontrib><description>Purpose - This paper aims to briefly describe the increasingly complex array of organizations influencing American healthcare-associated infection (HAI) prevention efforts during the modern era of infection control.Design methodology approach - This paper is a narrative review.Findings - The modern era of hospital infection control began in the 1950s, but received relatively little publicity until the dawn of the twenty-first century. Since then, there has been a wave of unprecedented magnitude in individual state legislation mandates followed by a shift from state to federal agency activity. The resulting programs are in varying stages of development, ability, sustainability, and coordination.Practical implications - Many government and healthcare entities are in uncharted territory with this new area of activity, facing challenges in having to coordinate work with many new and unfamiliar partners. Perspectives explored in this part of the Universities Council Symposium help by mapping out the various stakeholders in order to foster a research agenda through better understanding of powerful political players and their influence.Originality value - This is one of the first efforts to describe and map the evolving range of state and federal forces influencing hospitals' efforts to prevent healthcare-associated infections.</description><identifier>ISSN: 1477-7274</identifier><identifier>ISSN: 2059-4631</identifier><identifier>EISSN: 1758-6038</identifier><identifier>EISSN: 2059-464X</identifier><identifier>DOI: 10.1108/14777271211220853</identifier><language>eng</language><publisher>Bradford: Emerald Group Publishing Limited</publisher><subject>Accountability ; Accreditation ; American Recovery & Reinvestment Act 2009-US ; Arrays ; Collaboration ; Departments ; Developmental stages ; Disease control ; Disease management ; Disease prevention ; Electronic data interchange ; Epidemiology ; Federal agencies ; Funding ; Governments ; Health care ; Health care policy ; Hospitals ; Infection ; Information systems ; Initiatives ; Legislation ; Magnitude ; Mapping ; Medical research ; Medicare ; Narratives ; Nosocomial infections ; Occupational safety ; Patient safety ; Players ; Public health ; Publicity ; Surveillance ; Sustainability ; Sustainable development ; Territories</subject><ispartof>Clinical governance, 2012, Vol.17 (2), p.141-148</ispartof><rights>Emerald Group Publishing Limited</rights><rights>Copyright Emerald Group Publishing Limited 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c284t-f000650b44902b9c0dabf26a414931b9593e8e8e9fa425ad347f63bc1f5424813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.emerald.com/insight/content/doi/10.1108/14777271211220853/full/pdf$$EPDF$$P50$$Gemerald$$H</linktopdf><linktohtml>$$Uhttps://www.emerald.com/insight/content/doi/10.1108/14777271211220853/full/html$$EHTML$$P50$$Gemerald$$H</linktohtml><link.rule.ids>314,776,780,961,4010,11614,12825,27900,27901,27902,30976,30977,52661,52664</link.rule.ids></links><search><creatorcontrib>Birnbaum, David</creatorcontrib><creatorcontrib>Stricof, Rachel</creatorcontrib><title>State and federal legislative interests</title><title>Clinical governance</title><description>Purpose - This paper aims to briefly describe the increasingly complex array of organizations influencing American healthcare-associated infection (HAI) prevention efforts during the modern era of infection control.Design methodology approach - This paper is a narrative review.Findings - The modern era of hospital infection control began in the 1950s, but received relatively little publicity until the dawn of the twenty-first century. Since then, there has been a wave of unprecedented magnitude in individual state legislation mandates followed by a shift from state to federal agency activity. The resulting programs are in varying stages of development, ability, sustainability, and coordination.Practical implications - Many government and healthcare entities are in uncharted territory with this new area of activity, facing challenges in having to coordinate work with many new and unfamiliar partners. Perspectives explored in this part of the Universities Council Symposium help by mapping out the various stakeholders in order to foster a research agenda through better understanding of powerful political players and their influence.Originality value - This is one of the first efforts to describe and map the evolving range of state and federal forces influencing hospitals' efforts to prevent healthcare-associated infections.</description><subject>Accountability</subject><subject>Accreditation</subject><subject>American Recovery & Reinvestment Act 2009-US</subject><subject>Arrays</subject><subject>Collaboration</subject><subject>Departments</subject><subject>Developmental stages</subject><subject>Disease control</subject><subject>Disease management</subject><subject>Disease prevention</subject><subject>Electronic data interchange</subject><subject>Epidemiology</subject><subject>Federal agencies</subject><subject>Funding</subject><subject>Governments</subject><subject>Health care</subject><subject>Health care policy</subject><subject>Hospitals</subject><subject>Infection</subject><subject>Information systems</subject><subject>Initiatives</subject><subject>Legislation</subject><subject>Magnitude</subject><subject>Mapping</subject><subject>Medical research</subject><subject>Medicare</subject><subject>Narratives</subject><subject>Nosocomial infections</subject><subject>Occupational safety</subject><subject>Patient safety</subject><subject>Players</subject><subject>Public health</subject><subject>Publicity</subject><subject>Surveillance</subject><subject>Sustainability</subject><subject>Sustainable development</subject><subject>Territories</subject><issn>1477-7274</issn><issn>2059-4631</issn><issn>1758-6038</issn><issn>2059-464X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>BENPR</sourceid><recordid>eNqN0E1LxDAQBuAgCq6rP8BbwYMerM4kkzQ5yuIXLHhQzyVtE-nSbdekK_jvzbKCoCxIDgnMMxnmZewU4QoR9DVSURS8QI7IOWgp9tgEC6lzBULvp3eq5wnQITuKcQHAgQAm7Px5tKPLbN9k3jUu2C7r3FsbOzu2Hy5r-9EFF8d4zA687aI7-b6n7PXu9mX2kM-f7h9nN_O85prG3AOAklARGeCVqaGxlefKEpIRWBlphNPpGG-JS9sIKrwSVY1eEieNYsoutv-uwvC-TpPLZRtr13W2d8M6lghcgEmb_YtyrY1ClejZL7oY1qFPiyQFWhFIs1G4VXUYYgzOl6vQLm34TKjcpFz-STn1XG573HITXvPT8puWq8YnDjv4zglfscKHBQ</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Birnbaum, David</creator><creator>Stricof, Rachel</creator><general>Emerald Group Publishing Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0U~</scope><scope>1-H</scope><scope>7QJ</scope><scope>7RV</scope><scope>7TA</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AXJJW</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>F~G</scope><scope>JG9</scope><scope>K6X</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0Q</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>2012</creationdate><title>State and federal legislative interests</title><author>Birnbaum, David ; Stricof, Rachel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-f000650b44902b9c0dabf26a414931b9593e8e8e9fa425ad347f63bc1f5424813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Accountability</topic><topic>Accreditation</topic><topic>American Recovery & Reinvestment Act 2009-US</topic><topic>Arrays</topic><topic>Collaboration</topic><topic>Departments</topic><topic>Developmental stages</topic><topic>Disease control</topic><topic>Disease management</topic><topic>Disease prevention</topic><topic>Electronic data interchange</topic><topic>Epidemiology</topic><topic>Federal agencies</topic><topic>Funding</topic><topic>Governments</topic><topic>Health care</topic><topic>Health care policy</topic><topic>Hospitals</topic><topic>Infection</topic><topic>Information systems</topic><topic>Initiatives</topic><topic>Legislation</topic><topic>Magnitude</topic><topic>Mapping</topic><topic>Medical research</topic><topic>Medicare</topic><topic>Narratives</topic><topic>Nosocomial infections</topic><topic>Occupational safety</topic><topic>Patient safety</topic><topic>Players</topic><topic>Public health</topic><topic>Publicity</topic><topic>Surveillance</topic><topic>Sustainability</topic><topic>Sustainable development</topic><topic>Territories</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Birnbaum, David</creatorcontrib><creatorcontrib>Stricof, Rachel</creatorcontrib><collection>CrossRef</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Nursing & Allied Health Database</collection><collection>Materials Business File</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>Asian & European Business Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Materials Research Database</collection><collection>British Nursing Index</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>European Business Database</collection><collection>Healthcare Administration Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical governance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Birnbaum, David</au><au>Stricof, Rachel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>State and federal legislative interests</atitle><jtitle>Clinical governance</jtitle><date>2012</date><risdate>2012</risdate><volume>17</volume><issue>2</issue><spage>141</spage><epage>148</epage><pages>141-148</pages><issn>1477-7274</issn><issn>2059-4631</issn><eissn>1758-6038</eissn><eissn>2059-464X</eissn><abstract>Purpose - This paper aims to briefly describe the increasingly complex array of organizations influencing American healthcare-associated infection (HAI) prevention efforts during the modern era of infection control.Design methodology approach - This paper is a narrative review.Findings - The modern era of hospital infection control began in the 1950s, but received relatively little publicity until the dawn of the twenty-first century. Since then, there has been a wave of unprecedented magnitude in individual state legislation mandates followed by a shift from state to federal agency activity. The resulting programs are in varying stages of development, ability, sustainability, and coordination.Practical implications - Many government and healthcare entities are in uncharted territory with this new area of activity, facing challenges in having to coordinate work with many new and unfamiliar partners. Perspectives explored in this part of the Universities Council Symposium help by mapping out the various stakeholders in order to foster a research agenda through better understanding of powerful political players and their influence.Originality value - This is one of the first efforts to describe and map the evolving range of state and federal forces influencing hospitals' efforts to prevent healthcare-associated infections.</abstract><cop>Bradford</cop><pub>Emerald Group Publishing Limited</pub><doi>10.1108/14777271211220853</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-7274 |
| ispartof | Clinical governance, 2012, Vol.17 (2), p.141-148 |
| issn | 1477-7274 2059-4631 1758-6038 2059-464X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1023091751 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); Emerald Complete Journals |
| subjects | Accountability Accreditation American Recovery & Reinvestment Act 2009-US Arrays Collaboration Departments Developmental stages Disease control Disease management Disease prevention Electronic data interchange Epidemiology Federal agencies Funding Governments Health care Health care policy Hospitals Infection Information systems Initiatives Legislation Magnitude Mapping Medical research Medicare Narratives Nosocomial infections Occupational safety Patient safety Players Public health Publicity Surveillance Sustainability Sustainable development Territories |
| title | State and federal legislative interests |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T08%3A35%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=State%20and%20federal%20legislative%20interests&rft.jtitle=Clinical%20governance&rft.au=Birnbaum,%20David&rft.date=2012&rft.volume=17&rft.issue=2&rft.spage=141&rft.epage=148&rft.pages=141-148&rft.issn=1477-7274&rft.eissn=1758-6038&rft_id=info:doi/10.1108/14777271211220853&rft_dat=%3Cproquest_cross%3E1022889616%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1008640596&rft_id=info:pmid/&rfr_iscdi=true |